Press Release Details
Colfax Reports First Quarter 2014 Results
COLFAX REPORTS FIRST QUARTER 2014 RESULTS
· First quarter net income per dilutive share of
· First quarter net sales increased 11.3% (5.6% organically) to
· Gas- and fluid-handling finished the period with record backlog of
For the first quarter of 2014, net income was
Net sales were
First quarter gas- and fluid-handling orders were
Adjusted net income, adjusted net income per share, adjusted operating income, organic sales growth and organic order growth are not financial measures calculated in accordance with generally accepted accounting principles in the U.S. ("GAAP"). See below for a description of the measures' usefulness and a reconciliation of these measures to their most directly comparable GAAP financial measures.
Non-GAAP Financial Measures and Other Adjustments
Colfax has provided in this press release financial information that has not been prepared in accordance with GAAP. These non-GAAP financial measures are adjusted net income, adjusted net income per share, adjusted operating income, organic sales growth and organic order growth. Adjusted net income, adjusted net income per share and adjusted operating income exclude restructuring and other related charges and, for the 2013 period, asbestos coverage litigation expense. Adjusted net income and adjusted net income per share for the first quarter of 2014 exclude the preferred stock conversion inducement payment. The effective tax rates used to calculate adjusted net income and adjusted net income per share are 27.0% and 30.5% for the first quarters of 2014 and 2013, respectively. Organic sales growth and organic order growth exclude the impact of acquisitions and foreign exchange rate fluctuations. These non-GAAP financial measures assist Colfax in comparing its operating performance on a consistent basis because, among other things, they remove the impact of asbestos insurance coverage issues, restructuring and other related charges, and preferred stock conversion inducement payment.
Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of non-GAAP financial measures presented above to GAAP results has been provided in the financial tables included in this press release.
Conference Call and Webcast
Colfax will host a conference call to provide details about its results on Thursday, April 24, 2014 at
About
CAUTIONARY NOTE CONCERNING FORWARD LOOKING STATEMENTS:
This press release may
contain forward-looking statements, including forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning Colfax's plans, objectives, expectations and intentions and other statements that are not historical or current fact. Forward-looking statements are based on Colfax's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause Colfax's results to differ materially from current expectations include, but are not limited to factors detailed in Colfax's reports filed with the
The term "Colfax" in reference to the activities described in this press release may mean one or more of Colfax's global operating subsidiaries and/or their internal business divisions and does not necessarily indicate activities engaged in by
Contact:
Farand Pawlak, Director of Investor Relations
301-323-9054
Condensed Consolidated Statements of Operations
Dollars in thousands, except per share data
(Unaudited)
Three Months Ended | |||||||
| | ||||||
Net sales | $ | 1,054,331 | $ | 947,143 | |||
Cost of sales | 728,699 | 656,418 | |||||
Gross profit | 325,632 | 290,725 | |||||
Selling, general and administrative expense | 231,582 | 214,184 | |||||
Restructuring and other related charges | 6,312 | 4,214 | |||||
Operating income | 87,738 | 72,327 | |||||
Interest expense | 12,322 | 23,289 | |||||
Income before income taxes | 75,416 | 49,038 | |||||
Provision for income taxes | 20,579 | 16,763 | |||||
Net income | 54,837 | 32,275 | |||||
Less: income attributable to noncontrolling interest, net of taxes | 8,047 | 4,640 | |||||
Net income attributable to | 46,790 | 27,635 | |||||
Dividends on preferred stock | 2,348 | 5,082 | |||||
Preferred stock conversion inducement payment | 19,565 | - | |||||
Net income available to | $ | 24,877 | $ | 22,553 | |||
Net income per share- basic and diluted | $ | 0.22 | $ | 0.21 |
Reconciliation of GAAP to Non-GAAP Financial Measures
Dollars in thousands, except per share data
(Unaudited)
Three Months Ended | |||||||
| | ||||||
Adjusted Operating Income | |||||||
Operating income | $ | 87,738 | $ | 72,327 | |||
Restructuring and other related charges | 6,312 | 4,214 | |||||
Asbestos coverage litigation expense | - | 1,706 | |||||
Adjusted operating income | $ | 94,050 | $ | 78,247 | |||
Adjusted operating income margin | 8.9 | % | 8.3 | % |
Three Months Ended | |||||||
| | ||||||
Adjusted Net Income | |||||||
Net income attributable to | $ | 46,790 | $ | 27,635 | |||
Restructuring and other related charges | 6,312 | 4,214 | |||||
Asbestos coverage litigation expense | - | 1,706 | |||||
Tax adjustment(1) | (1,488 | ) | - | ||||
Adjusted net income | $ | 51,614 | $ | 33,555 | |||
Adjusted net income margin | 4.9 | % | 3.5 | % | |||
Adjusted Net Income Per Share | |||||||
Net income available to | $ | 24,877 | $ | 22,553 | |||
Restructuring and other related charges | 6,312 | 4,214 | |||||
Asbestos coverage litigation expense | - | 1,706 | |||||
Preferred stock conversion inducement payment | 19,565 | - | |||||
Tax adjustment(1) | (1,488 | ) | - | ||||
Adjusted net income available to | 49,266 | 28,473 | |||||
Dividends on preferred stock(2) | 2,348 | - | |||||
Less: adjusted net income attributable to participating securities(2) | - | 3,655 | |||||
$ | 51,614 | $ | 24,818 | ||||
Weighted-average shares outstanding - diluted | 119,832,595 | 95,153,498 | |||||
Adjusted net income per share | $ | 0.43 | $ | 0.26 | |||
Net income per share- basic and diluted (in accordance with GAAP) | $ | 0.22 | $ | 0.21 |
__________
(1) The effective tax rates used to calculate adjusted net income and adjusted net income per share are 27.0% and 30.5% for the first quarter of 2014 and 2013, respectively.
(2) Adjusted net income per share for periods prior to
Change in Sales, Orders and Backlog
Dollars in millions
(Unaudited)
Net Sales | Orders | Backlog at Period End | ||||||||||||||||||
$ | % | $ | % | $ | % | |||||||||||||||
As of and for the three months ended | $ | 947.1 | $ | 502.1 | $ | 1,438.5 | ||||||||||||||
Components of Change: | ||||||||||||||||||||
Existing Businesses | 53.5 | 5.6 | % | 11.1 | 2.2 | % | (87.5 | ) | (6.1 | )% | ||||||||||
Acquisitions(1) | 85.1 | 9.0 | % | 72.1 | 14.4 | % | 243.5 | 16.9 | % | |||||||||||
Foreign Currency Translation | (31.4 | ) | (3.3 | )% | (1.9 | ) | (0.4 | )% | (2.5 | ) | (0.1 | )% | ||||||||
Total | 107.2 | 11.3 | % | 81.3 | 16.2 | % | 153.5 | 10.7 | % | |||||||||||
As of and for the three months ended | $ | 1,054.3 | $ | 583.4 | $ | 1,592.0 |
(1) Represents the incremental sales, orders and order backlog as a result of our acquisitions of
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source:
News Provided by Acquire Media